<DOC>
	<DOC>NCT00092586</DOC>
	<brief_summary>The purpose of this 6-week study is to compare the reduction in specific levels of cholesterol in patients with high cholesterol.</brief_summary>
	<brief_title>Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)</brief_title>
	<detailed_description>The duration of treatment is 6 weeks.</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>High cholesterol levels that are identified by specific laboratory values Active liver disease Any condition or situation which would interfere with participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>